This study will test the feasibility, safety, and evidence for efficacy of psilocybin administration in participants with obsessive compulsive disorder (OCD). This will serve as a preliminary proof of concept study for future larger studies aimed to investigate the utility, cognitive mechanisms, and neural correlates of this intervention.
4 Primary · 0 Secondary · Reporting Duration: 1 month post session 2
30 Total Participants · 2 Treatment Groups
Primary Treatment: Immediate Psilocybin · No Placebo Group · Phase < 1
Age 21 - 70 · All Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
|Johns Hopkins University School of Medicine||100.0%|